|Number of samples:||20|
|Release date:||Sep 19 2017|
|Last update date:||Nov 20 2018|
|Diseases:||Alzheimer Disease, Amyotrophic Lateral Sclerosis, Tooth Loss, Neurodegenerative Diseases, X-Linked Combined Immunodeficiency Diseases|
|Dataset link||The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases IV|
Illumina NextSeq500 was used to identify disease-associated vs. homeostatic molecular microglia signature in microglia in different disease models and transgenic models. Bulk microglia (1,000 cells/sample) FCRLS+ sorted microglia.